How Many Billions Is Enough? Prioritizing Profits Over Patients With Cystic Fibrosis.

CFTR modulators have transformed CF but are some of the most expensive medications on the market and are over-priced compared to the value given. The high price of CFTR modulators leaves people with CF dependent on Vertex's copay assistance programs. Despite record-breaking profits, Vertex is drastically decreasing its copayment assistance programs, so people with CF will have to pay thousands of dollars monthly for CFTR modulators or discontinue therapy. Vertex continues to put profits above the lives of people with CF This article is protected by copyright. All rights reserved.